Main
>
ONCOLOGY (**)
>
Leukemia>Lymphoblastic>Acute>Ph+***
>
Treatment
>
Co.: USA. B. Brand Dasatinib *
>
Patent>US Expiration: 2020. 04.03
Patent>US Expiration: 2020. 04.03's products
This section has no products